Apricot Therapeutics is a spatially resolved cellular information company dedicated to the field of functional precision medicine, in which treatment is informed by high-plex image-based profiling of the complex drug responses of individual cells that make up each patient's unique cancer. We offer a full suite of profiling products that extract a large amount of spatially resolved information, from molecule to phenotype, to identify how each cell in a tumor responds to a series of drugs. The data accumulated on Apricot's cellular drug response information platform offer improved treatment decisions of patients and prioritization of drug candidates. This empowers clinicians, academic researchers and drug developers to advance the post-genomics era of predictive medicine and drug design.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Sempacherstrasse 15, Lucerne,lu 6003,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://apricotx.com
- HQ
- Lucerne, LU
Apricot Bio Questions
Apricot Bio's website is https://apricotx.com
Apricot Bio's LinkedIn profile is https://ch.linkedin.com/company/apricot-bio
Apricot Bio has
4 employees.
View email and phone details for 4
employees at Apricot Bio.
Apricot Bio's industry is
Biotechnology Research
Apricot Bio's top competitors are
Witec Ag,
Cellx Biosolutions,
Juvion Health Sciences,
Aukera Therapeutics,
Abrinca Genomics,
Inkvivo Technologies Ag,
Nerai Bioscience,
Hemostod,
Amporin Pharmaceuticals,
Enantios.
Apricot Bio's categories are Biotechnology Research
Apricot Bio's founding year is 2022
